** Shares of Gilead Sciences GILD.O rise 3.1% to $110.69 in morning trade
** U.S. Supreme Court rules in favor of Obamacare preventive care task force
** The task force helps guarantee that health insurers cover preventive care such as cancer screenings at no cost to patients
** Cancer test makers such as Exact Sciences EXAS.O up 4.8% at $54.32 and Guardant Health GH.O up 1.6%
** Labcorp Holdings LH.N, which offers cancer tests, is up 1.5% at $260.73
** The justices in a 6-3 decision reversed the lower court's ruling on Friday which will likely help in allaying investor fears on insurance coverage for PrEP or pre-exposure prophylaxis drugs
** PrEP drugs are approved in the U.S. to prevent HIV infection which are made by Gilead and by ViiV Healthcare, a joint venture of GSK GSK.L, Pfizer PFE.N and Shionogi 4507.T
** Including session's move, GILD up 17.3%, EXAS down 3.9%, LH up 13.5%, GH up 65% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.